Bristol Myers Squibb (BMY) Revenue (2009 - 2026)
Bristol Myers Squibb (BMY) recorded Revenue of $12.97 billion in Q2 2026, up 5.7% from $12.27 billion a year earlier and up 12.9% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Revenue (2009 - 2026) Analysis & Trends
On a TTM basis, Bristol Myers Squibb's Revenue came in at $49.19 billion as of Jun 30, 2026, up 3.1% year-over-year; for FY2025, it came in at $48.19 billion, down 0.2% from FY2024.
- Annual Revenue has a five-year compound annual growth rate of 2.5% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $48.3 billion in FY2024 (+7.3%), $45.01 billion in FY2023 (-2.5%), $46.16 billion in FY2022 (-0.5%) and $46.39 billion in FY2021 (+9.1%).
- The Q2 2026 figure is the highest quarterly Revenue in data going back to Q1 2009.
- On a year-over-year basis, Revenue has increased for five consecutive quarters, with growth averaging 2.9% over the last eight quarters.
- Peak year-over-year performance for Revenue in the last five years was growth of 10.3% in Q3 2021, against a decline of 5.6% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.49 billion (Q1 2026), $12.5 billion (Q4 2025) and $12.22 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Bristol Myers Squibb | 120.21 Bn | 71.48 Bn | 9.25 Bn | 12.97 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.97 Bn |
| Mar 31, 2026 | 11.49 Bn |
| Dec 31, 2025 | 12.50 Bn |
| Sep 30, 2025 | 12.22 Bn |
| Jun 30, 2025 | 12.27 Bn |
| Mar 31, 2025 | 11.20 Bn |
| Dec 31, 2024 | 12.34 Bn |
| Sep 30, 2024 | 11.89 Bn |
| Jun 30, 2024 | 12.20 Bn |
| Mar 31, 2024 | 11.87 Bn |
| Dec 31, 2023 | 11.48 Bn |
| Sep 30, 2023 | 10.97 Bn |
| Jun 30, 2023 | 11.23 Bn |
| Mar 31, 2023 | 11.34 Bn |
| Dec 31, 2022 | 11.41 Bn |
| Sep 30, 2022 | 11.22 Bn |
| Jun 30, 2022 | 11.89 Bn |
| Mar 31, 2022 | 11.65 Bn |
| Dec 31, 2021 | 11.99 Bn |
| Sep 30, 2021 | 11.62 Bn |
API Access
Bristol Myers Squibb Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();